Labshake search
Citations for R&D Systems :
1 - 32 of 32 citations for Phospholipase A2 Activating Peptide since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2019Quote: ... recombinant mouse ephrin-A2-Fc (R&D systems cat. no. 8415-A2) or Fc (Millipore Sigma cat ...
-
bioRxiv - Cancer Biology 2023Quote: ... The AXL-activating antibody AF154 (R&D Systems) was used at 300 ng/mL ...
-
bioRxiv - Cancer Biology 2021Quote: ... 0.1 mM E1 Ubiquitin Activating Enzyme (#E-304 R&D systems), 0.2 mM E2 conjugase (UbcH5c ...
-
bioRxiv - Molecular Biology 2019Quote: ... Recombinant human ubiquitin-activating enzyme E1 (UBE1) was purchased from R&D systems (Cat. # E-305). Recombinant human UbcH5a was purchased from R&D systems (Cat ...
-
bioRxiv - Bioengineering 2023Quote: ... B cell activating medium was supplemented with 5 ug/mL anti-CD40 antibody (R&D systems) and 20 ng/mL IL-4 (R&D Systems ...
-
bioRxiv - Molecular Biology 2021Quote: ... purified 6xHis-Clr4 protein was mixed with human Ubiquitin-activating Enzyme (UBE1, R&D systems E-305), human UbcH5c/UBE2D3 (R&D systems E2-627) ...
-
bioRxiv - Molecular Biology 2019Quote: ... Recombinant human SUMO activating enzyme E1 (SAE1/UBA2) was purchased from R&D systems (Cat. # E-315) Recombinant Human Ubc9 was purchased from (Cat ...
-
bioRxiv - Biochemistry 2020Quote: All proteins described herein for in vitro analyses were expressed and purified as recombinant proteins with the exception of E1 activating enzyme UBE1 and heavy isotope labeled ubiquitin (both purchased from R&D Systems). Recombinant ubiquitin ...
-
bioRxiv - Immunology 2022Quote: ... which were coated with 0.5 µg/mL of rhEphA2 (R&D Systems, Minneapolis, MN, USA: #3035-A2-100) or poly-L-lysine (Sigma ...
-
bioRxiv - Cell Biology 2022Quote: ... 100μg of GST-NEDD4△52 was bound to 10 μl Glutathione sepharose resin and incubated with 50 nM ubiquitin activating enzyme UBA1 (R&D Systems, E305025), 750 nM ubiquitin conjugating enzyme UBCH5B (R&D Systems ...
-
bioRxiv - Cell Biology 2021Quote: ... directly after UV irradiation or pre-treated 1 hour before irradiation with proteasome inhibitor MG132 (Enzo, 50 µM) or NEDD8 E1 Activating Enzyme Inhibitor (NAEi) MLN4924 (R&D systems, 10 µM) where indicated ...
-
bioRxiv - Biochemistry 2020Quote: ... Fluorogenic peptide substrates were obtained from R&D systems, where Mca-YVADAPK(Dnp)-OH (ES007 ...
-
bioRxiv - Neuroscience 2021Quote: ... + β-heregulin peptide (R&D Systems, Cat# 396-HB-050) + forskolin (Cayman Chemical ...
-
bioRxiv - Cell Biology 2019Quote: ... a fluorogenic peptide substrate of MMPs (R&D systems, USA). The fluorgenic substrate (5 μM ...
-
bioRxiv - Neuroscience 2024Quote: ... recombinant control peptide (R&D systems, cat. #4460, Accession # P01863) is mouse melanoma cell line ...
-
bioRxiv - Cancer Biology 2019Quote: ... and CXCR4 antagonist peptide AMD3100 were procured from R&D systems. All chemicals and antibodies were obtained from Sigma unless specified otherwise.
-
bioRxiv - Immunology 2023Quote: ... using either PCSK9 peptides or recombinant mPCSK9/hPCSK9 protein (R&D Systems) as the coating antigen ...
-
bioRxiv - Cell Biology 2021Quote: ... cells were treated with RGDS peptide (10 μg/mL, R&D systems, MN, USA) (20 ...
-
Direct intracellular visualization of Ebola virus-receptor interaction by in situ proximity ligationbioRxiv - Microbiology 2020Quote: ... incubated with the fluorogenic peptide substrate Z-FR-AMC (150 μM; R&D Systems) and measured at a fluorometer following a 0 to 30 min incubation (ƛEx = 390 nm ...
-
bioRxiv - Cell Biology 2021Quote: ... NHEKs were induced to differentiate by addition of 1.2 mM CaCl2 to growth medium with or without addition of 1 μg/mL ephrin A1-FC peptide (R&D Systems) for the indicated times ...
-
bioRxiv - Neuroscience 2022Quote: ... The cells were cultured for 96 hours with MOG35-55 peptide (50 μg/mL) and Th17-polarizing factors as follows: recombinant murine (rm)IL-23 (8 ng/ml; R&D Systems), rmIL-1α (10 ng/ml ...
-
bioRxiv - Biochemistry 2020Quote: ... Verification of TIMP activity in vitro using activated MMP-2 and the fluorogenic peptide substrate MCA-Pro-Leu-Gly-Leu-DPA-Ala-Arg-NH2 was performed as per the protocol provided by R&D Systems.
-
bioRxiv - Immunology 2022Quote: ... at a final concentration of 60 pmol/peptide/mL in CTLm supplemented with 400 U/mL IL-4 and 10 ng/mL IL-7 (R&D Systems) for three days ...
-
bioRxiv - Bioengineering 2019Quote: ... Primary antibodies (1:300 dilutions of rat-anti-C-peptide (DSHB; GN-ID4-S) and goat anti-PDX1 (R&D Systems; AF2419) were left on overnight ...
-
bioRxiv - Physiology 2020Quote: ... and probed with either an affinity-purified antibody fraction of mouse antiserum to a synthetic peptide of human cystatin-s corresponding to amino acid residues 21-141 (AF1296, R&D Systems) or an affinity-purified goat antibody raised against a peptide mapping at the C-terminus of human amylase (sc-12821 ...
-
bioRxiv - Immunology 2021Quote: ... fifty microliters of stimulant pepmixes (JPT peptides) resuspended in RPMI+10%FBS (R10) with recombinant mouse IL-2 (rmIL-2) (R&D Systems) were added to each well ...
-
bioRxiv - Microbiology 2023Quote: PLY-treated H292 monolayers or PMNs in suspension were treated with 1U PLY and incubated for 30 min at 37 °C with 10 μM fluorogenic peptide MMP substrate (Mca-PLAQAV-Dpa-RSSSR-NH2, R&D Systems) diluted in 25 mM Tris buffer ...
-
bioRxiv - Genetics 2020Quote: ... Cells were incubated in 0.5% serum-containing media before treatment with 200 ng/mL recombinant Shh N-terminal peptide (R&D Systems, 1314-SH) diluted in dimethyl formamide (DMF).
-
bioRxiv - Neuroscience 2020Quote: ... or the newly designed FRET Aβ34-site peptide (10 µM) were digested at 37° C by human BACE2 (R&D systems, 1 ng/µL) in presence or absence of the stated inhibitors for 2h ...
-
bioRxiv - Cancer Biology 2022Quote: PBMC (2×106 per well) were stimulated in 24-well plates with peptide (individual/pool) plus recombinant IL-2 (R&D Systems Europe Ltd.) at a final concentration of 5μg/mL and 20IU/mL ...
-
bioRxiv - Neuroscience 2023Quote: Cortical neurons were treated with either 1.5 µM Aβ or rat recombinant TIMP-1 peptide (R&D systems, Cat# 580-RT-010, Minneapolis, USA) at 100 ng/ml32 or a combination of both for 16 h as shown in figures.
-
bioRxiv - Molecular Biology 2023Quote: ... and Fluorogenic Peptide Substrate VII: Z-Leu-Arg-4-methyl-7-coumarylamide (Z-LR-AMC)(Catalog # ES008) were purchased from R&D Systems (Minneapolis, MN, USA). The enzyme reactions were initiated upon addition of ice-cold of hrCTSL (96pM ...